Under the agreement, the two parties will jointly implement education and training activities (both offline and online) related to disease awareness, prevention, and treatment options. Key priorities include: enhancing healthcare professionals’ capabilities by updating the latest evidence on disease burden, clinical trials, and preventive treatment for critical respiratory illnesses and serious infections; enriching pharmacists’ knowledge and clinical experience through scientific conferences; at the same time, upgrade real-world data on prevention and treatment, especially for patients with noncommunicable chronic diseases, to develop an educational documentation system for Long Châu’s AI platform, supporting healthcare professionals in accessing information effectively.

Pfizer Vietnam and Long Chau signed a Memorandum of Understanding to improve healthcare quality

Respiratory infections remain a persistent public health threat, ranging from common conditions such as colds, influenze, pharynitis and laryngitis to more severe illnesses such as bronchitis and pneumonia. A notable challenge is that many of these diseases share similar early symptoms such as mild fever, cough, sore throat, and nasal congestion, which can lead to misdiagnosis or complacency. This is especially dangerous for the infants and elderly, who are more vulnerable and at higher risk of severe progression once infected.(1)

Moreovers, pharmacies often serve as a familiar “healthcare touchpoint” where Vietnamese seek initial consultation(2), choose suitable medications, or receive guidance before visiting specialized healthcare facilities. Pharmacists therefore play a crucial role in helping communities identify symptoms, provide first care advice, and reduce the burden on the healthcare system.

Mr. Darrell Oh, General Director of Pfizer Vietnam, speaking at the signing ceremony

Speaking at the signing ceremony, Mr. Darrell Oh, General Director of Pfizer Vietnam, said: “This collaboration marks the next important step in Pfizer’s long-term commitment to improving healthcare quality in Vietnam. With more than 175 years of global experience, we bring scientific expertise and innovation to support Long Chau in enhacing healthcare professional capablitities. We believe that the alignment of our strengths and vision will help drive positive, practical and sustainable changes for Vietnam’s heathcare system.”

Ms. Nguyen Do Quyen, Deputy CEO of FPT Retail and COO of Long Châu Pharmacy and Vaccination Centers, shared: “We believe that the combination of Pfizer’s leading research capabilities and scientific advancements, together with Long Châu’s extensive distribution network of 2,240 pharmacies and 190 vaccination centers, supported by our team of highly qualified pharmacists and doctors, will create a comprehensive, sustainable, and breakthrough healthcare foundation for the community. This is not only a synergy of capabilities but also an alignment of vision for a healthier Vietnam.”

Ms. Nguyen Do Quyen, Deputy CEO of FPT Retail and COO of Long Châu Pharmacy and Vaccination Centers, sharing at the signing ceremony

The collaboration between Pfizer Vietnam and Long Châu not only underscores a long-term commiment to investing in healthcare human resources, but also marks a significant step forward in the trend of intergrating global pharmaceutical expertise with and the local healthcare system, aiming to enhance healthcare quality to international standards.